INTEGRATED CORE STRATEGIES (US) LLC → TETRAPHASE PHARMACEUTICALS INC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on TETRAPHASE PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2020-07-01	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2020-06-30	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2020-06-26	SC	LA JOLLA PHARMACEUTICAL CO	—	—	view →
2020-06-11	SC	ARMISTICE CAPITAL, LLC	—	—	view →
2020-03-20	SC	ARMISTICE CAPITAL, LLC	—	—	view →

Other Filings by INTEGRATED CORE STRATEGIES (US) LLC

Filed	Form	Issuer	Stake	Shares
2026-06-18	SCHEDULE 13G	Edesa Biotech, Inc. EDSA	—	—	view →
2026-06-17	SCHEDULE 13G	TPG Inc. TPGXL	—	—	view →
2026-06-11	SCHEDULE 13G	Once Upon a Farm, PBC OFRM	—	—	view →
2026-06-10	SCHEDULE 13G	Quince Therapeutics, Inc. QNCX	—	—	view →
2026-05-26	SCHEDULE 13G	Amanat Acquisition Corp AMAN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →